BDK PHARMA PRIVATE LIMITED
BDK PHARMA PRIVATE LIMITED is a TAMIL NADU based PRIVATE LIMITED company, Registered at dated 05-SEP-2023 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of BDK PHARMA PRIVATE LIMITED is U47721TN2023PTC163430 and registration number is 163430.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC CHENNAI India. Authorized share capital of BDK PHARMA PRIVATE LIMITED is Rs. 1500000 and its paid up capital is Rs. 100000. It aspire to serve in TRADING activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
BDK PHARMA PRIVATE LIMITED has 2 directors ERSHAD AHAMED, NOOHUMOHAMEDAMEERFIZEL AHAMED FARIS,
The registered Email address of BDK PHARMA PRIVATE LIMITED is ahmed.faris@outlook.com and its registered address is SUIT NO.5, 8TH FLOOR, DOOR NO. 1A, JHAVER PLAZA, NUNGAMBAKKAM HIGH ROAD, NUNGAMBAKKAM HIGH ROAD CHENNAI CHENNAI TN 600034 IN TAMIL NADU TAMIL NADU india 600034.
The current status of BDK PHARMA PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
BDK PHARMA PRIVATE LIMITED
ROC CHENNAI
ACTIVE
TRADING
U47721TN2023PTC163430
05-SEP-2023
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1500000
100000
CONTACT DETAILS
600034
INDIA
SUIT NO.5, 8TH FLOOR, DOOR NO. 1A, JHAVER PLAZA, NUNGAMBAKKAM HIGH ROAD, NUNGAMBAKKAM HIGH ROAD CHENNAI CHENNAI TN 600034 IN
ahmed.faris@outlook.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
10308664 | ERSHAD AHAMED | Director | 05/09/2023 |
07051350 | NOOHUMOHAMEDAMEERFIZEL AHAMED FARIS | Director | 05/09/2023 |
Details Updated by Companies
Quick Links
- All Registered company of TAMIL NADU
- Company Registered in TAMIL NADU
- All Registered company of CHENNAI in TAMIL NADU
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.